Preventive fungicides are primarily used to prevent pathogen infection, while curative fungicides can inhibit the early development of certain pathogens after infection has already begun.
The biggest difference between the two is not which has stronger fungicidal activity, but rather at which stage of disease development they are effective.
Let’s take a simple example.
If your wheat crop has not yet shown signs of rust, but weather and field conditions are already highly conducive to pathogen infection, applying an appropriate preventive fungicide early on may be more effective than waiting until the leaves are covered with rust spots to treat the crop.
If the pathogen has just entered the leaves and the infection is still in its early stages, certain products with curative activity may still be able to inhibit the pathogen’s further growth.
However, “curative” does not mean that already necrotic leaves can be restored to health.
Only by understanding this can one truly grasp the difference in the use of these two types of fungicides. For pesticide importers, distributors, and brand owners, this is also a critical point to clarify when selecting active ingredients, developing product portfolios, and introducing products to customers.
A preventive fungicide, also known as a protectant fungicide, primarily reduces the risk of plant disease by providing protection before pathogens successfully infect the plant.
You can think of it as establishing a protective barrier before pathogens enter the plant.
However, this protection is not necessarily limited to a chemical film on the leaf surface. Some preventive fungicides rely primarily on surface residue to be effective, while others can penetrate plant tissues to provide protection before pathogens invade.
After pathogen spores land on the plant surface, they typically must undergo processes such as germination, invasion, and further growth before an infection can occur.
The role of preventive fungicides is to prevent pathogens from successfully establishing an infection before these processes begin or in their early stages.
For example, Mancozeb belongs to the FRAC M03 class of broad-spectrum protective fungicides.
It primarily inhibits spore germination and early infection by affecting several key biochemical processes in the pathogen. Its effectiveness largely depends on the appropriate application timing and foliar coverage.
You can learn more about this typical protective fungicide by exploring Mancozeb’s mode of action.
It is important to note that preventive application does not mean the field is completely free of pathogens.
More accurately, it provides protection to healthy plant tissue before pathogens can establish new, active infections.
A curative fungicide typically refers to a fungicide that can inhibit the early development of a pathogen after it has already begun to infect the plant.
Here, “curative” should more often be understood as Early Curative Activity or Kickback Activity.
For example, a pathogen has penetrated the leaf surface and is growing inside the leaf, but no lesions are yet visible to the naked eye.
If a product with the appropriate Early Curative Activity is applied at this stage, it may prevent or slow the further progression of the infection.
This is what is known as early curative activity.
After a pathogen enters plant tissue, it must continue to grow and spread before visible symptoms gradually develop.
Some fungicides can penetrate plant tissues and interfere with the pathogen’s physiological activities, thereby suppressing early infection.
For example:
Tebuconazole and Difenoconazole both belong to the DMI fungicides in FRAC Group 3.
By inhibiting sterol biosynthesis in pathogens, they disrupt the formation of normal cell membranes, thereby limiting the further growth of susceptible pathogens.
Under appropriate conditions regarding crops, pathogens, and product registration, both can provide preventive effects and a certain degree of early infection suppression.
If you would like to learn more about the differences between these two active ingredients, please refer to Tebuconazole vs. Difenoconazole.
However, please note:
The effective window for curative fungicides is typically quite limited.
They cannot guarantee the elimination of all infections once lesions have appeared extensively and tissue has been severely damaged.
Therefore, having curative activity does not mean you should wait until the disease is severe before applying the fungicide.
Now that we understand how both types work, we can compare them directly from a practical application perspective.
| Comparison | Preventive Fungicide | Curative Fungicide |
|---|---|---|
| Primary Objective | Prevent new infections from occurring | Suppress early-stage infections that have already begun |
| Typical Application Timing | Before infection or during high-risk periods | Early stages of infection; in some cases, symptoms have not yet appeared |
| Target | Uninfected tissue or the initial stages of infection | Susceptible pathogens that have already entered plant tissue |
| Effect on existing lesions | Generally cannot eliminate existing lesions | May limit the further progression of some diseases, but cannot repair necrotic tissue |
| Common examples | Mancozeb, Chlorothalonil | Certain products such as Tebuconazole and Difenoconazole |
| Relationship to Systemic Fungicides | May be either contact or systemic | Often require some tissue activity, but this does not mean all systemic fungicides have curative effects |
| Primary Benefits | Preventative protection of healthy tissue | Control of disease progression within a limited early infection window |
| Main Limitations | Established infections usually cannot be reversed | Limited window of effectiveness, influenced by pathogen susceptibility |
| Product Selection Criteria | Disease risk, coverage effectiveness, residual efficacy, and registered uses | Stage of infection, pathogen susceptibility, product mode of action, and registered uses |
There is another point that is often misunderstood.
Certain curative fungicides also exhibit preventive activity.
Therefore, these two modes of action do not represent entirely mutually exclusive product categories.
In actual production, a single fungicide can provide both preventive and limited early curative effects, though its value varies depending on the stage of disease development.
Why does the same fungicide work well when applied early, but its effectiveness may decline significantly when applied after the disease has become severe?
To answer this question, we must first understand how pathogens cause disease.
Pathogen spores reach plants via wind, rain, agricultural practices, or other means.
This does not necessarily mean infection will occur.
Spores also require suitable conditions, such as temperature and humidity, and must successfully complete the infection process.
This stage is typically a critical period when preventive protection proves most valuable.
Under suitable conditions, the pathogen germinates and invades the plant.
Infection may have already occurred, but there are no visible changes on the leaf surface at this time.
Some fungicides with early infection-suppressing capabilities can be effective at this stage.
The pathogen has already established itself within the plant tissues, but symptoms have not yet become apparent.
The absence of visible lesions does not mean the plant is not infected.
This is why one cannot rely solely on visually observable symptoms to determine the timing of fungicide application.
For certain diseases, by the time farmers first notice obvious symptoms, the pathogen may have already been growing within the plant tissue for some time.
As the infection progresses, plants may exhibit:
leaf spots, yellowing, necrosis, mold growth, rust spots, or other disease symptoms.
At this stage, some fungicides may still limit new infections or slow the progression of certain pathogens.
However, tissue that has already died usually cannot be restored.
Many pathogens produce new spores on infected tissue, which are then spread to other healthy parts of the plant.
If the disease enters a stage of continuous transmission, disease pressure in the field may increase rapidly.
Some fungicides possess antisporulant activity, which can reduce the spore-forming ability of certain pathogens.
However, this is not the same as completely eradicating an existing infection.
These stages illustrate a very important fact:
The effectiveness of fungicides depends not only on the active ingredient chosen but also on whether the appropriate disease control window is captured.
This is the issue that most often leads to misunderstandings among customers.
The answer is: it’s not that simple.
Suppose a tomato leaf already has dark brown lesions, and some of the tissue has died.
Even if a fungicide with curative activity is applied, these necrotic areas will typically not turn green again.
So, is the fungicide still effective?
It may still be effective.
If the product is effective against the target pathogens and complies with registered usage requirements, it may help:
Suppress infections that are still in their early stages.
Slow the further spread of certain pathogens.
Protect healthy, uninfected tissue on the leaves.
Reduce the occurrence of new infections.
In some cases, inhibit the formation of new spores.
However, the specific effects achievable still depend on the product.
Therefore, when disease has already appeared in the field, you shouldn’t just ask:
“Is there a curative fungicide?”
Instead, you should ask:
“How far has the infection progressed? How much healthy tissue remains to be protected?”
This is the key factor in determining the subsequent management approach.
No.
“Preventive” and “Curative” describe at which stage of pathogen infection a fungicide is effective.
In contrast, “Contact,” “Translaminar,” and “Systemic” describe how the active ingredient is distributed and moves on the plant’s surface or within its tissues.
These are not the same classification systems.
Contact fungicides primarily remain on the treated surface.
They typically require good spray coverage to ensure the active ingredient covers the areas that need protection.
Common examples include multi-site protectants such as Mancozeb and Chlorothalonil.
Systemic fungicides can penetrate plant tissues and move to some extent depending on the characteristics of the active ingredient.
Some products can provide protection before infection occurs and may also be effective against certain early-stage infections.
However:
‘Systemic’ does not mean “Curative.”
Just because a fungicide can penetrate a plant does not mean it can necessarily control an established infection.
Conversely, a preventive fungicide does not necessarily remain only on the plant’s surface.
Understanding these two distinct classification dimensions can help avoid making incorrect judgments when comparing products.
Whether a fungicide has preventive or early curative activity cannot be determined solely by its product name.
One must also consider the product’s FRAC group, mode of action, target pathogens, and actual application conditions.
Below are the technical classifications of some common active ingredients.
| Active Ingredient | FRAC Group | Key Mode of Action |
|---|---|---|
| Mancozeb | M03 | Multisite surface protection, primarily used to prevent new infections |
| Chlorothalonil | M05 | Multisite protective action, dependent on good surface coverage |
| Tebuconazole | 3 | DMI; provides preventive action and partial suppression of early infections |
| Difenoconazole | 3 | DMI; may be used for prevention and early disease management in accordance with registration requirements |
| Azoxystrobin | 11 | QoI, primarily positioned for prevention and early-stage protection against infection |
| Boscalid | 7 | SDHI, primarily effective before or during the early stages of pathogen infection |
| Metalaxyl | 4 | Provides systemic activity and early infection suppression against certain susceptible Oomycete pathogens |
| Cymoxanil | 27 | Provides a short-window, early infection suppression within tissues against certain Oomycete pathogens |
This table is intended only to aid in understanding common modes of action and does not imply that every ingredient can be used on all crops or against all diseases.
For example, Metalaxyl and Cymoxanil are primarily used for the management of specific oomycete diseases, including certain types of downy mildew and late blight.
They cannot simply be used as a universal treatment for all fungal leaf spot or rust diseases.
Similarly, the actual effectiveness of azoxystrobin and boscalid may also be affected by the resistance levels of the target pathogens.
Therefore, the FRAC Group is an important reference, but it cannot replace the registered label of a specific product or local disease data.
We’ll explain this using three relatively common agricultural scenarios.
Suppose a particular wheat-growing region is prone to leaf rust every year.
Recent weather conditions have been favorable for disease development, and symptoms have already been observed in neighboring fields.
However, no obvious rust spots have yet appeared in your own field.
At this point, you should determine whether preventive protection is necessary based on field risk, variety resistance, crop growth stage, and local control recommendations.
If a small number of rust spots have already appeared, the situation is different.
At this stage, there may be both established infections and leaves that are still healthy.
Selecting a product that remains effective against the local leaf rust pathogen can help protect the remaining healthy leaf area and limit the spread of the disease.
However, if a large number of leaves are already severely rusted and necrotic, spraying will not restore them to normal.
Therefore, the goal of applying fungicides for wheat rust should be to protect healthy leaves that have productive value, rather than attempting to restore tissue that has already died.
Now let’s look at tomatoes.
Early blight is typically associated with Alternaria pathogens.
Suppose there has been continuous rainfall, field humidity is high, and sporadic lesions have already begun to appear on the lower leaves of the plants.
If you simply wait for the lesions to grow larger and then look for so-called “strong curative fungicides,” you will often have already missed the optimal window for control.
In this situation, you need to assess:
Whether the current lesions are still spreading, whether healthy leaves are at risk of new infection, and whether weather conditions will continue to favor disease development.
If permitted by product registration, fungicides with appropriate preventive or early curative activity may help limit further disease progression.
At the same time, you should improve plant ventilation, remove severely infected plant debris, and adjust irrigation management based on actual conditions.
The most important thing here is not to find a product that makes all lesions disappear.
Rather, the goal is to minimize new infections as much as possible and protect the leaves that can continue to photosynthesize.
The third example is Grape Downy Mildew.
Its pathogen belongs to the Oomycetes, not true fungi.
In vineyards, the disease can spread rapidly if the weather remains consistently humid.
Preventive protection is crucial in disease management.
For example, copper oxychloride can provide surface protection under appropriate conditions, while Cymoxanil has some ability to inhibit early infection by certain susceptible oomycete pathogens.
However, Cymoxanil’s early window of effectiveness is limited and should not be interpreted as capable of controlling the disease at any stage of its development.
Therefore, in situations with a high risk of downy mildew, it is more prudent to implement protective measures based on disease risk, weather conditions, and label requirements, rather than waiting until leaves and grape clusters are heavily infected before beginning management.
Yes, and this approach is very practical in an appropriate disease management strategy.
However, not all preventive and curative active ingredients are suitable for direct mixing.
It is necessary to first confirm whether they are effective against the same target pathogen, whether their registration permits such a combination, and whether the two active ingredients have a reasonable synergistic effect.
For example:
Mancozeb 64% + Metalaxyl 8% WP
This combination combines the broad-spectrum protective action of Mancozeb with the systemic activity of Metalaxyl against certain susceptible oomycete pathogens.
On crops and for diseases where registration is approved, this combination provides both foliar protection and control of certain early-stage infections.
You can view specific product information for Mancozeb 64% + Metalaxyl 8% WP.
Another example is Cymoxanil + Copper Oxychloride.
In this combination, Copper Oxychloride primarily provides surface protection, while Cymoxanil acts against certain early stages of Oomycete infection.
However, combining the two ingredients does not necessarily mean the product is more effective than either ingredient alone.
The following factors must also be considered:
Do the two active ingredients cover the target pathogens?
Do they actually complement each other?
Is there already resistance to these ingredients in the local area?
Do the product’s formulation and mixture stability meet requirements?
Do the application rate, interval, and maximum number of applications comply with the label?
A truly valuable formulation is one in which different active ingredients play distinct roles at the correct disease stages, rather than simply increasing the number of ingredients.
This is a factor that cannot be overlooked when selecting a fungicide.
Suppose a market has been using products from the same FRAC Group repeatedly over a long period.
Even if a different brand is used, the target pathogens may have already developed reduced susceptibility to this group of modes of action.
For example:
Tebuconazole and Difenoconazole both belong to FRAC Group 3.
Switching from tebuconazole to difenoconazole does not constitute rotation between different modes of action.
Similarly, if the target pathogen has already developed resistance to a particular FRAC 11 fungicide, one cannot continue to assume it remains effective simply because it originally possessed good preventive activity.
Therefore, sound disease management must take into account:
local pathogen susceptibility, the FRAC group of the active ingredient, the number of consecutive applications, and other non-chemical control measures.
Furthermore, applying fungicides early is generally more effective for maintaining control than repeatedly using them after severe infection has set in; however, this does not mean that preventive spraying should be carried out indefinitely when there is no risk of disease.
What should actually be done is:
Determine whether application is necessary based on disease risk, and manage resistance risk based on the FRAC Group.
Do not view preventive fungicides as an “insurance product” that can be used at any time or repeatedly.
For pesticide importers and distributors, “preventive” and “curative” are not just technical concepts; they also directly influence the design of product portfolios.
Suppose you are planning to add three fungicides to your local market.
Rather than simply selecting three active ingredients with high sales volumes, it is better to first understand the disease problems your customers are actually facing.
| Buyer Question | Why is it necessary to confirm |
|---|---|
| Target Crop | Different crops face different disease risks |
| Target Disease | It is necessary to identify the specific target pathogen, rather than just a symptom category such as “leaf spot” |
| Disease Timing | Determines whether the product serves a preventive or early-infection control role |
| FRAC Group | Used for resistance management and product portfolio planning |
| Preventive / Early Curative Activity | Clarifies the product’s actual application purpose |
| Local Resistance | Determines whether existing active ingredients remain reliable |
| Formulation | Affects storage, dilution, application, and packaging requirements |
| PHI / MRL | Relates to harvest scheduling and market access for agricultural products |
| Registration | Confirms whether target crops, diseases, and uses are permitted |
| Technical Documents | Provides support for product registration, procurement, and distributor training |
For example, a distributor whose primary market consists of horticultural crops such as grapes, tomatoes, and potatoes may need to consider both protective products and products active against specific early-stage infections.
However, when actually placing an order, one should not simply ask the supplier:
“I need a curative fungicide.”
Such a request is too broad.
A better procurement request should specify:
target crops, target diseases, pathogen types, application stages, active ingredients, formulation types, target markets, and registration requirements.
For product combinations that need to address both surface protection and partial early-stage infection control, please refer to POMAIS’s Cymoxanil 42 g/kg + Copper Oxychloride 689.5 g/kg WP”.
Product examples like this help illustrate how active ingredients with different modes of action can be incorporated into a single commercial formulation.
However, the final product’s crop suitability, disease spectrum, application rates, and registration status must still be verified on a case-by-case basis according to the requirements of the target country.
If you’re looking for a simple rule of thumb, consider this:
When the pathogen has not yet successfully infected the plant, prioritize preventive protection; when infection has just begun, certain products with early curative activity may still be valuable; once the disease becomes severe, the focus should shift to protecting remaining healthy tissue, limiting new infections, and adjusting the overall management strategy.
However, in practice, decisions cannot be based solely on the presence or absence of visible lesions.
This is because the pathogen may already be present, even if no obvious symptoms have appeared yet.
Therefore, a more reliable approach is to make a judgment based on the following factors.
| Field Conditions | Key Management Considerations |
|---|---|
| No obvious disease yet, but high risk of infection | Evaluate preventive protection based on disease forecasts and local recommendations |
| Weather conditions favorable for infection are present, but no symptoms yet | Assess current infection risk and the early control window permitted by the product label |
| A small number of lesions have just appeared | Identify the pathogen, protect healthy tissue, and limit further infection |
| The disease has spread significantly in the field | Evaluate suitable pesticides, resistance risks, disease pressure, and integrated management measures |
| A large number of leaves have already died | Do not expect fungicides to restore tissue; focus on evaluating the value of protecting the remaining yield |
| Effectiveness declines with consecutive applications of the same product | Investigate application timing, pathogen identification, product coverage, and FRAC resistance issues |
There is another practical issue worth noting.
Early spraying is not always more cost-effective.
If the risk of field disease is very low, early application may not yield sufficient returns.
Therefore, a sound preventive strategy should be based on disease history, weather, variety resistance, crop growth stages, and economic risk.
Selecting the right fungicide is not simply about pursuing “ stronger curative efficacy,” but rather about taking the right measures as early as possible before the disease causes severe losses.
It cannot be simply assumed that they can. Some curative fungicides can inhibit the further development of pathogens in the early stages of infection, but they generally cannot repair plant tissue that has already died, nor can they guarantee the elimination of severe infections.
Can Preventive Fungicides Be Used After Disease Appears?
Provided the specific product’s registration permits it, an appropriate preventive fungicide can be used to protect uninfected tissue and reduce the risk of subsequent new infections. However, it generally cannot eliminate an established infection.
Many triazole fungicides, such as tebuconazole and difenoconazole, possess both preventive activity and may offer limited early curative activity against certain susceptible pathogens. However, this capability should not be interpreted as a means to treat all existing diseases.
Not necessarily. A well-designed combination can provide complementary effects, provided that each active ingredient is effective against the target pathogens, the FRAC groups are appropriately matched, and the mixture complies with local registration and mixing requirements. Not all mixtures will improve control efficacy.
Whether farmers are developing field control plans or importers are establishing fungicide portfolios for local markets, they should start with actual disease problems rather than deciding first whether to purchase “preventive” or “curative” products.
A well-designed fungicide portfolio should be able to clearly answer the following questions:
Which crops and diseases does it primarily target?
Which products are used during stages with a higher risk of infection?
Which products possess specific Early Curative Activity?
How should FRAC Group rotation be managed among different products?
Which combinations are suitable for local climate, application practices, and registration requirements?
For importers, distributors, and brand owners, providing information on target markets, major crops, lists of diseases, existing products, and registration requirements helps further evaluate suitable active ingredients, formulations, and product portfolios.
Ultimately, it is important to remember:
The value of preventive fungicides lies in preventing infections from occurring; The value of curative fungicides lies primarily in suppressing early-stage infections that have already begun. What truly determines the effectiveness of disease control is often not whether a product is labeled “preventive” or “curative,” but whether you are using a product suitable for the target pathogen at the correct stage of disease development.